Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00311727 · ClinicalTrials.gov registry record · NA
Cell-Mediated Immune Responses to Influenza A/H5N1 Vaccine
A NA study of Influenza, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- Completed
- Registry status
- NA
- Development phase
- 339
- Enrollment target
- 3
- Study locations
NCT00311727 is a NA study of Influenza that has completed, run by National Institute of Allergy and Infectious Diseases (NIAID). The registered enrollment target is 339 participants, below the 36,802-participant average among 156 other Influenza trials with a reported enrollment target (99% lower). The trial reports 3 study locations across 3 states.
The verdict
NCT00311727, a NA study of Influenza, has completed, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- COMPLETED
- Registry status
- NA
- Development phase
- 339 participants
- Enrollment target
- 3
- Study locations
Study Summary
This study may determine whether laboratory studies of people's blood cells, who have received vaccines against H5 influenza, or "bird flu," will help to decide if the vaccines are going to be prevent disease effectively. About 232 people, 18 years and older, enrolled in the studies "A Randomized, Double-Blinded, Placebo-Controlled, Phase I/II, Dose-Ranging Study of the Safety, Reactogenicity, and Immunogenicity of Intramuscular Inactivated Influenza A/H5N1 Vaccine in Healthy Adults" and "in Healthy Elderly Adults" will participate. Participants may be involved in this study for about 14 months. Procedures may include blood draws, physical exams, and medical history reviews.
Conditions Studied
Interventions
- BIOLOGICAL Influenza A/H5N1
Study Locations (3)
Maryland
- University of Maryland Baltimore - Baltimore
New York
- University of Rochester - Rochester
Tennessee
- Vanderbilt University - Nashville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 339 participants |
| Start Date | 2005-10 |
| Est. Completion | 2006-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00311727
The ClinicalTrials.gov registry entry for NCT00311727 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 339 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 36,802-participant average among 156 other Influenza trials with a reported enrollment target (99% lower). The listed sponsor is National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Influenza appearing as the primary indexed condition, and to 1 intervention - of which Influenza A/H5N1 is the first listed.
NCT00311727 reports 3 study locations spanning 3 distinct geographic areas - top geographies include Maryland, New York, Tennessee.
Frequently Asked Questions
What is clinical trial NCT00311727 about?
NCT00311727 is a clinical study titled "Cell-Mediated Immune Responses to Influenza A/H5N1 Vaccine". This study may determine whether laboratory studies of people's blood cells, who have received vaccines against H5 influenza, or "bird flu," will help to decide if the vaccines are going to be prevent disease effectively. About 232 people, 18 years and older, enrolled in the studies "A Randomized, D...
What is the current status of trial NCT00311727?
This trial is currently completed. It is a NA study. The enrollment target is 339 participants. The study started on 2005-10. Estimated completion is 2006-03.
What conditions does trial NCT00311727 study?
This clinical trial studies the following conditions: Influenza.
What interventions are being tested in trial NCT00311727?
The interventions under investigation include: Influenza A/H5N1 (BIOLOGICAL).
Who is sponsoring clinical trial NCT00311727?
This trial is sponsored by National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00311727 being conducted?
This trial has 3 study locations across Maryland, New York, Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Influenza
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Influenza Immunization in Adults Over Age 75
RECRUITING · NA
-
H5N1 Milk Detection Study
RECRUITING · NA
-
Immune Defense Protein Impact On Respiratory Immune Outcomes
RECRUITING · NA
-
Dime La VerDAD: Verify, Debunk, and Disseminate
RECRUITING · NA
-
The INFLUENTIAL Trial- Evaluation of National Inpatient Influenza Vaccination Program
RECRUITING · NA
-
Impact of High Dietary Fiber on Microbiome and Vaccine Responses
ACTIVE NOT RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.